Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Strainer Bags

May 23, 2011 11:34 am | Product Releases | Comments

Seward Limited has further enhanced the application range of its Strainer bags to include sterile processing of tissue samples for primary cell preparation. The bags are Gamma irradiated sterile and available in a range of sizes.


ICP-OE Spectrometers

May 23, 2011 11:28 am | Product Releases | Comments

PerkinElmer Inc. announced the launch of its Optima 8x00 series of Inductively Coupled Plasma Optical Emission Spectrometers. The Optima 8x00 ICP-OES platform offers improved performance and reduced operating costs.


Anavex Stepping Up Dosage in Phase 1 Trial

May 23, 2011 11:23 am | News | Comments

Anavex Life Sciences Corp. announced that the Safety Review Committee for ANAVEX 2-73, its lead candidate for Alzheimer’s disease, unanimously approved skipping the 5 mg dose and moving directly to the 10 mg dose step.


Abbott Applies for Cancer Test Approval

May 23, 2011 11:14 am | News | Comments

Abbott announced it filed premarket approval applications to the U.S. Food and Drug Administration for a new molecular diagnostic test designed to detect abnormal gene rearrangements in non-small-cell lung cancer tumors.


J & J Buying J B Chemicals for $260M

May 23, 2011 10:48 am | News | Comments

Johnson & Johnson said that its Cilag GmbH unit will expand its business in Russia by buying the over-the-counter brands of J B Chemicals & Pharmaceuticals Ltd. for $260 million in cash.


Lilly Spinout to Sell Xigris

May 23, 2011 10:45 am | News | Comments

Drugmaker Eli Lilly and Co. said it will work with some private investors to create a privately held biotechnology company to sell the severe sepsis treatment Xigris and possibly develop other drugs.


FDA Clears Incivek for Hepatitis

May 23, 2011 10:43 am | News | Comments

The Food and Drug Administration approved Vertex Pharmaceuticals Inc.'s hepatitis C drug Incivek Monday, making it the second new treatment to be approved in the last two weeks.


Drug Target for Breast Cancer Identified

May 23, 2011 7:56 am | News | Comments

Researchers at Imperial College London have identified a new protein involved in the development of drug resistance in breast cancer that could be a target for new treatments.


Cephalon Wins Restraining Order Against Mylan

May 23, 2011 7:52 am | News | Comments

FRAZER, Pa. (AP) - Drugmaker Cephalon Inc. reported on May 20 that a U.S. district court judge granted its request for a restraining order barring Mylan Inc. from launching a generic version of the muscle relaxant Amrix.


Sutent Approved for Pancreatic Tumors

May 23, 2011 7:48 am | News | Comments

Pfizer Inc. announced the U.S. Food and Drug Administration (FDA) approved Sutent (sunitinib malate) as the first anti-VEGF therapy to treat progressive pancreatic neuroendocrine tumors (NET) in patients with locally advanced or metastatic disease.


FDA Expands Pfizer Drug Approval for Rare Cancer

May 23, 2011 7:25 am | News | Comments

WASHINGTON (AP) - The Food and Drug Administration (FDA) expanded approval of a Pfizer drug to treat a rare form of pancreatic cancer.


Auxilium Gets $7.5M Payment from Pfizer for Xiapex

May 23, 2011 7:20 am | News | Comments

MALVERN, Pa. (AP) - Auxilium Pharmaceuticals Inc. received a $7.5 million milestone from Pfizer following the launch of the specialty drug Xiapex in Germany.


Biomarker Predicts Taxane-Induced Neuropathy

May 23, 2011 7:13 am | News | Comments

Researchers at Indiana University identified a genetic biomarker that causes neuropathy among breast cancer patients using taxanes.


Motorized Microscope Stage

May 23, 2011 5:40 am | Product Releases | Comments

Prior Scientific’s H117P2NN flat top stage for the Nikon Ti series of inverted microscopes,  can assist researchers conducting prolonged live cell studies.


Atomic-level Spectroscopy

May 23, 2011 5:31 am | Product Releases | Comments

FEI has extended its ChemiSTE Technology to enableatomic-level energy dispersive X-ray (EDX) spectroscopy across the periodic table.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.